Skip to content
Tuesday, November 10, 2026
Focus Pro Media

Patients Stopping Weight-Loss Medications Gain Back Weight at a Quadrupled Rate Than Those on Conventional Diets

Image of medical syringe and weighing machine
Weight management involves ongoing approaches.

Fresh analysis suggests that individuals who stop using popular slimming jabs like Mounjaro or Wegovy can put back on lost weight much more quickly than those who end conventional diet and exercise plans.

Findings released in a prominent medical journal demonstrates that while obese people often shed substantial amounts of their body weight while using the jabs, the mass comes back at an average rate of nearly a kilo each month after stopping.

"Individuals purchasing these treatments should be informed of the risk of rapid rebound weight gain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb.

Such speed of recovery implies a reversion to pre-treatment mass within about 18 months.

Comparing Therapies

The study, which examined 37 of trials involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with other pills.

Scientists point out that individuals who lose weight through diet and exercise generally experience a more gradual creep back—approximately 100 grams monthly—post-intervention.

Explaining the Fast Rebound

Doctors believe the mechanism of the drugs is key to understanding the heightened weight return.

These medications mimic a body's own chemical called GLP-1, which moderates feelings of fullness.

"Artificially providing GLP-1 concentrations several times higher than normal might result in the body to produce less of its endogenous hormone, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.

"Stopping of this GLP-1 'fix' means appetite is unsuppressed, making overeating much more probable."

An Ongoing Issue?

Health authorities suggest the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes.

Professionals argue that, considering the likelihood of relapse, the treatment is often ongoing.

This view is echoed by drug manufacturers, who say that the results "highlight the persistent character of excess weight," similar to managing conditions like high blood pressure.

User Accounts

Individuals who have stopped the jabs explain a powerful return of appetite.

"I experienced a trigger activating and you become extremely hungry," recalled one woman.

The struggle is compounded if users have not developed permanent dietary or behavioural modifications during therapy.

Widespread Use

Survey data suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with interest being substantial.

  • Adoption is greater among females compared to males.
  • The middle-aged age group shows the greatest level of interest.
  • Many access the medications through private healthcare rather than public health services.

In conclusion, researchers emphasize that while the jabs are powerful tools for weight loss, they are not a standalone solution and long-term success hinges on combined lifestyle management.

About the author

David Holloway

Elena Vance is a seasoned digital strategist with over a decade of experience in crafting innovative marketing campaigns and driving brand engagement across various industries.

Focus Pro Media

Type to search articles.